BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Proprietary Plasma-Generated Nitric Oxide Technology Being Developed at ADM Tronics for Origin Produces Positive Interim Results from Phase IIb Diabetic Foot Ulcer Study

  ADM Tronics Unlimited announced today that its client Origin has today announced positive interim results from its “GENESIS” US-based dose-ranging Phase IIb trial in the treatment of Diabetic Foot Ulcers utilizing a proprietary plasma technology.

  October 26, 2017

   · 

  4 min read
• Business

  CohBar to Announce Third Quarter 2017 Financial Results and Host Conference Call for Shareholders on November 13, 2017

  The company will host a conference call for the shareholders at 2:00 p.m. PT the same day.

  October 26, 2017

   · 

  2 min read
• Business

  Agilent Technologies to Host Webcast of Fourth-Quarter Fiscal Year 2017 Financial Results Conference Call

  Agilent Technologies Inc. will release fourth-quarter fiscal 2017 financial results after the stock market closes on November 20.

  October 26, 2017

   · 

  1 min read
• BioMidwest

  EndoGastric Solutions Announces Expanded Medicare Reimbursement for Transoral Incisionless Fundoplication (TIF) Procedure

  Medicare beneficiaries in 10 Midwestern and Northeastern states will soon have reimbursed access to the Transoral Incisionless Fundoplication (TIF) procedure following a decision by Medicare Administrative Contractor (MAC) National Government Services, Inc. (NGS).

  October 26, 2017

   · 

  5 min read
• Business

  Histogenics Corporation to Report Third Quarter 2017 Financial Results on November 9, 2017

  The Company will host a conference call and webcast at 8:30 a.m. ET to review financial and operational results for the quarter ended September 30, 2017 and provide a company update.

  October 26, 2017

   · 

  2 min read
• 

  Deals

  Ultragenyx and Dimension Announce Expiration of Hart-Scott-Rodino Waiting Period for Ultragenyx’s Acquisition of Dimension

  Ultragenyx and Dimension struck the m&a deal on October 2, 2017,

  October 26, 2017

   · 

  6 min read
• Business

  AIT Therapeutics Strengthens Executive Team with Three Key Senior Hires as Company Prepares for Upcoming Clinical Milestones

  Joining the Company are Giora Davidai, M.D. as Chief Medical Officer, Rhona Shanker as Director of Regulatory Affairs, and Professor Asher Tal, M.D. as Senior Vice President of Clinical Research.

  October 26, 2017

   · 

  5 min read
• Drug Development

  BeyondSpring Announces the First Patient Enrolled in China in its Global Phase II/III Trial with Plinabulin for the Prevention of Chemotherapy-Induced Neutropenia

  The enrollment took place at the Harbin Medical University Cancer Hospital in Harbin, China.

  October 26, 2017

   · 

  4 min read
• Business

  UroGen Pharma Expands Leadership Team, Appoints Industry Veterans Jeffrey Bova as Vice President of Commercial and James Ottinger as Vice President of Regulatory Affairs

  The two new hires will report to UroGen’s CEO and will be based in the company’s New York office.

  October 26, 2017

   · 

  4 min read
• Business

  ReWalk Robotics to Report Third Quarter 2017 Financial Results on November 2, 2017

  ReWalk’s CEO and CFO will host a conference call to discuss the results.

  October 26, 2017

   · 

  1 min read